A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents
I4T-MC-JVDK - ClinicalTrials.gov - NCT02745769
The main purpose of this study is to evaluate the safety of ramucirumab (LY3009806) in combination with other targeted agents in participants with advanced cancers.
Trial Summary
Age Range
≥18 yearsConditions the trial is for
Advanced CancerWhat the trial is testing?
Abemaciclib, Merestinib, RamucirumabCould I receive a Placebo?
NoEnrollment Goal
23Trial Dates
Oct 21, 2016 - Jan 22, 2019How long will I be in the trial?
The duration of your participation depends on how well your disease responds to the study treatment and how many cycles of treatment you receive.Trial Phase
ILilly Trial Alerts
Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.
You will complete the questionnaire on another website.YesNo